Kuldeep Singh, J. Gupta, Devendra Pathak, Shivendra Kumar
{"title":"The Use of Enzyme Inhibitors in Drug Discovery: Current Strategies and Future Prospects","authors":"Kuldeep Singh, J. Gupta, Devendra Pathak, Shivendra Kumar","doi":"10.2174/1573408019666230731113105","DOIUrl":null,"url":null,"abstract":"\n\n: Enzyme inhibitors are an important therapeutic agent in drug discovery, as they can be used\nto manipulate biochemical pathways to treat a wide range of diseases. Current strategies for enzyme inhibition involve the use of small molecule inhibitors, natural products, or peptide-based inhibitors. These inhibitors can be used to target and modulate the activity of enzymes, which in turn can affect the\nprogression of a particular disease. The future of enzyme inhibitor-based drug discovery lies in the development of more selective and potent inhibitors, as well as the ability to target enzymes that are involved in multiple pathways. Additionally, there is significant potential for the use of enzyme inhibitors\nin combination with other therapeutic strategies, such as gene therapy. Finally, the development of novel computational strategies for the design and optimization of enzyme inhibitor-based drugs is an exciting area of research. Such strategies could lead to the discovery of new and more effective inhibitors,\nwhich would facilitate the development of improved treatments for a variety of diseases. Hence, this review focuses on some techniques for the discovery of enzyme inhibitors and their applications as various therapeutic agents.\n","PeriodicalId":35405,"journal":{"name":"Current Enzyme Inhibition","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Enzyme Inhibition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573408019666230731113105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
: Enzyme inhibitors are an important therapeutic agent in drug discovery, as they can be used
to manipulate biochemical pathways to treat a wide range of diseases. Current strategies for enzyme inhibition involve the use of small molecule inhibitors, natural products, or peptide-based inhibitors. These inhibitors can be used to target and modulate the activity of enzymes, which in turn can affect the
progression of a particular disease. The future of enzyme inhibitor-based drug discovery lies in the development of more selective and potent inhibitors, as well as the ability to target enzymes that are involved in multiple pathways. Additionally, there is significant potential for the use of enzyme inhibitors
in combination with other therapeutic strategies, such as gene therapy. Finally, the development of novel computational strategies for the design and optimization of enzyme inhibitor-based drugs is an exciting area of research. Such strategies could lead to the discovery of new and more effective inhibitors,
which would facilitate the development of improved treatments for a variety of diseases. Hence, this review focuses on some techniques for the discovery of enzyme inhibitors and their applications as various therapeutic agents.
期刊介绍:
Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.